Wiley Rein LLP | USA | 19 May 2014
On May 19, 2014, in Tobinick v. Olmarker, the U.S. Court of Appeals for the Federal Circuit (Lourie, Reyna,* Wallach) reversed and remanded the…
Wiley Rein LLP | USA | 22 Apr 2014
On April 22, 2014, in Braintree Labs., Inc. v. Novel Labs., the U.S. Court of Appeals for the Federal Circuit (Dyk, Prost,* Moore) affirmed-in-part…
Wiley Rein LLP | USA | 21 Apr 2014
On April 21, 2014, in Sanofi-Aventis Deutschland GmbH v. Glenmark Pharms. Inc., USA, the U.S. Court of Appeals for the Federal Circuit (Newman,* Linn…
Wiley Rein LLP | USA | 7 Apr 2014
The long awaited FDASIA Health IT Report proposes a strategy for calibrating regulatory oversight to risk and clarifying the regulatory obligations…
Wiley Rein LLP | USA | 19 Mar 2014
Applying Illinois law, an Illinois Appellate Court has held that a suit brought against a hospital by participants of a discontinued vaccine trial…
Wiley Rein LLP | USA | 14 Mar 2014
The recent controversy about AOL CEO Tim Armstrong's comments on employee health care expenses reflects ongoing confusion about the rules for…
Wiley Rein LLP | USA | 24 Feb 2014
The U.S. Food and Drug Administration (FDA) has proposed to reverse its 25-year old interpretation of the eligibility criteria for drug products to…
Wiley Rein LLP | USA | 24 Feb 2014
On February 24, 2014, in GlaxoSmithKline LLC v. Banner Pharmacaps, Inc., the U.S. Court of Appeals for the Federal Circuit (O'Malley, Wallach…
Wiley Rein LLP | USA | 20 Feb 2014
"[For purposes of 35 U.S.C. § 112,] the mere possibility of different results from different measurement techniques [regarding the claimed…